Review article · 2026 · Open access
Materials Control of Nitric Oxide in Cancer Immunotherapy
Advanced Materials · Published 14 November 2026 · DOI 10.1002/adma.75722
In brief
“Materials Control of Nitric Oxide in Cancer Immunotherapy” is a 2026 review article by Xiaodong Wang and 6 co-authors, published in Advanced Materials. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at Advanced Materials.
- Citations
- 0
- References
- 107
- Authors
- 7
Abstract
Nitric oxide (NO) can suppress antitumor immunity, support tumor adaptation, or promote immune-mediated killing, making its therapeutic manipulation highly dependent on exposure. This Review examines how materials control NO source, localization, release kinetics, and chemical fate in cancer immunotherapy, with particular attention to immune checkpoint blockade (ICB). We analyze polymeric donors, nanocarriers, injectable depots, and strategies for restricting endogenous NO production, linking their physicochemical properties to target exposure and immune function. Evidence from checkpoint-treated models is distinguished from mechanisms established with other therapies and from human associations. Comparative analyses separate donor capacity from measured NO exposure, carrier accumulation from cellular delivery, and distant-tumor control from demonstrated immune memory. Four overlapping endogenous contexts, comprising tumor adaptation, myeloid suppression, vascular dysfunction, and inflammatory effector activity, guide intervention design without constituting validated patient categories. We identify testable predictions concerning cellular selectivity, release kinetics, and spatial pharmacodynamic responses. Translation requires measurements that connect material behavior to a defined NO-dependent process while demonstrating preservation of beneficial endothelial and immune functions. This framework provides a basis for evaluating when localized NO delivery or selective inhibition may support ICB, while recognizing the limits of current preclinical and clinical evidence.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wang, X., Wang, Q., Wu, S., (2085), W. G., He, S., Zou, B., & Li, Z. (2026). Materials Control of Nitric Oxide in Cancer Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.75722
MLA 9
Wang, Xiaodong, et al. “Materials Control of Nitric Oxide in Cancer Immunotherapy.” Advanced Materials, 2026. https://doi.org/10.1002/adma.75722.
Chicago
Wang, Xiaodong, Qianqian Wang, Song Wu, Wei Gao (2085), Songjiang He, Bingwen Zou, and Zheng Li. 2026. “Materials Control of Nitric Oxide in Cancer Immunotherapy.” Advanced Materials. https://doi.org/10.1002/adma.75722.
Harvard
Wang, X. et al. (2026) ‘Materials Control of Nitric Oxide in Cancer Immunotherapy’, Advanced Materials. doi:10.1002/adma.75722.
IEEE
X. Wang et al., “Materials Control of Nitric Oxide in Cancer Immunotherapy,” Advanced Materials, 2026, doi: 10.1002/adma.75722.
BibTeX
@article{wang2026materials,
title = {{Materials Control of Nitric Oxide in Cancer Immunotherapy}},
author = {Wang, Xiaodong and Wang, Qianqian and Wu, Song and (2085), Wei Gao and He, Songjiang and Zou, Bingwen and Li, Zheng},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.75722},
url = {https://doi.org/10.1002/adma.75722}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- nitric oxide
- cancer immunotherapy
- immune checkpoint blockade
- nitric oxide donors
- nanocarriers
- release kinetics
- endogenous nitric oxide
- tumor adaptation
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wang, X., Wang, Q., Wu, S., (2085), W. G., He, S., Zou, B., & Li, Z. (2026). Materials Control of Nitric Oxide in Cancer Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.75722
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Advanced Materials: sign in and open the PDF from this page.
Who wrote this paper?
Xiaodong Wang, Qianqian Wang, Song Wu, Wei Gao (2085), Songjiang He, Bingwen Zou, Zheng Li.
What is the DOI of this paper?
10.1002/adma.75722, permanently at https://doi.org/10.1002/adma.75722. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.